Germline DNMT3A mutation in familial acute myeloid leukaemia.
AML
DNMT3A
germline
hereditary
predisposition
Journal
Epigenetics
ISSN: 1559-2308
Titre abrégé: Epigenetics
Pays: United States
ID NLM: 101265293
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
pubmed:
29
8
2020
medline:
13
1
2022
entrez:
29
8
2020
Statut:
ppublish
Résumé
Acute myeloid leukaemia (AML) is a heterogeneous myeloid malignancy characterized by recurrent clonal events, including mutations in epigenetically relevant genes such as
Identifiants
pubmed: 32856987
doi: 10.1080/15592294.2020.1809871
pmc: PMC8078744
doi:
Substances chimiques
DNMT3A protein, human
0
DNA (Cytosine-5-)-Methyltransferases
EC 2.1.1.37
DNA Methyltransferase 3A
EC 2.1.1.37
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
567-576Subventions
Organisme : NCI NIH HHS
ID : P30 CA016672
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI121403
Pays : United States
Références
Cancer Cell. 2014 Apr 14;25(4):442-54
pubmed: 24656771
N Engl J Med. 2014 Dec 25;371(26):2477-87
pubmed: 25426838
J Clin Oncol. 2017 Mar 20;35(9):1018-1028
pubmed: 28297620
Cell. 2012 Jul 20;150(2):264-78
pubmed: 22817890
PLoS One. 2007 May 02;2(5):e399
pubmed: 17476321
Clin Genet. 2017 Apr;91(4):623-628
pubmed: 27701732
J Med Genet. 2017 Dec;54(12):805-808
pubmed: 28432085
Cancer Cell. 2010 Dec 14;18(6):553-67
pubmed: 21130701
Nucleic Acids Res. 1999 Jun 1;27(11):2291-8
pubmed: 10325416
Am J Med Genet A. 2017 Nov;173(11):3022-3028
pubmed: 28941052
Biostatistics. 2004 Oct;5(4):557-72
pubmed: 15475419
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Genes Dev. 2013 Sep 15;27(18):1974-85
pubmed: 24065765
Epigenetics. 2014 Aug;9(8):1108-19
pubmed: 24866170
N Engl J Med. 2014 Dec 25;371(26):2488-98
pubmed: 25426837
Leukemia. 2014 Sep;28(9):1774-83
pubmed: 24699305
Nat Genet. 2014 Apr;46(4):385-8
pubmed: 24614070
Blood. 2013 Dec 12;122(25):4086-9
pubmed: 24167195
Nat Genet. 2011 Dec 04;44(1):23-31
pubmed: 22138693
Blood. 2015 Nov 26;126(22):2484-90
pubmed: 26492932
N Engl J Med. 2010 Dec 16;363(25):2424-33
pubmed: 21067377
Trends Biochem Sci. 2000 Jun;25(6):300-2
pubmed: 10838572
Cancer Cell. 2010 Mar 16;17(3):225-34
pubmed: 20171147
J Biol Chem. 2012 Sep 7;287(37):30941-51
pubmed: 22722925
Nat Genet. 2014 Aug;46(8):912-918
pubmed: 25017105
N Engl J Med. 2012 Mar 22;366(12):1079-89
pubmed: 22417203
PLoS Genet. 2011 Aug;7(8):e1002228
pubmed: 21852959
N Engl J Med. 2016 Sep 1;375(9):900-1
pubmed: 27579651
Nat Rev Cancer. 2015 Mar;15(3):152-65
pubmed: 25693834
Am J Hematol. 2015 Aug;90(8):732-6
pubmed: 26016821
Am J Med Genet A. 2017 Jan;173(1):250-253
pubmed: 27991732
Blood. 2013 Jun 6;121(23):4769-77
pubmed: 23632886
Nat Protoc. 2011 Apr;6(4):468-81
pubmed: 21412275
Wellcome Open Res. 2018 Apr 23;3:46
pubmed: 29900417
N Engl J Med. 2013 May 30;368(22):2059-74
pubmed: 23634996
N Engl J Med. 2016 Jun 9;374(23):2209-2221
pubmed: 27276561
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
Bioinformatics. 2011 Jun 1;27(11):1571-2
pubmed: 21493656
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
Blood. 2017 Jul 27;130(4):424-432
pubmed: 28600339
Genome Res. 2012 Oct;22(10):1995-2007
pubmed: 22637570
Nature. 2012 Feb 15;483(7390):474-8
pubmed: 22343901
Oncotarget. 2016 Mar 22;7(12):14172-87
pubmed: 26871476